PubRank

Mark Gompels

Author PubWeight™ 22.29‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Impact of late diagnosis and treatment on life expectancy in people with HIV-1: UK Collaborative HIV Cohort (UK CHIC) Study. BMJ 2011 3.72
2 Rate of AIDS diseases or death in HIV-infected antiretroviral therapy-naive individuals with high CD4 cell count. AIDS 2007 2.47
3 Impact on life expectancy of HIV-1 positive individuals of CD4+ cell count and viral load response to antiretroviral therapy. AIDS 2014 2.27
4 Late diagnosis in the HAART era: proposed common definitions and associations with mortality. AIDS 2010 1.57
5 HAE international home therapy consensus document. Allergy Asthma Clin Immunol 2010 1.42
6 The cost-effectiveness of early access to HIV services and starting cART in the UK 1996-2008. PLoS One 2011 1.09
7 Tuberculosis among people with HIV infection in the United Kingdom: opportunities for prevention? AIDS 2009 1.09
8 CD4 counts and the risk of systemic non-Hodgkin's lymphoma in individuals with HIV in the UK. Haematologica 2009 1.07
9 Rising population cost for treating people living with HIV in the UK, 1997-2013. PLoS One 2010 0.96
10 Cost-effectiveness of early treatment with first-line NNRTI-based HAART regimens in the UK, 1996-2006. PLoS One 2011 0.93
11 Laboratory adverse events and discontinuation of therapy according to CD4(+) cell count at the start of antiretroviral therapy. AIDS 2014 0.87
12 Failure to achieve a CD4+ cell count response on combination antiretroviral therapy despite consistent viral load suppression. AIDS 2014 0.82
13 Virological response to initial antiretroviral regimens containing abacavir or tenofovir. J Infect Dis 2009 0.81
14 Effects of age on antiretroviral plasma drug concentration in HIV-infected subjects undergoing routine therapeutic drug monitoring. J Antimicrob Chemother 2013 0.81
15 Outcomes in the first year after initiation of first-line HAART among heterosexual men and women in the UK CHIC Study. Antivir Ther 2011 0.81
16 Lower healthcare costs associated with the use of a single-pill ARV regimen in the UK, 2004-2008. PLoS One 2012 0.79
17 A Cross-Sectional Study on Attitudes to and Understanding of Risk of Acquisition of HIV: Design, Methods and Participant Characteristics. JMIR Res Protoc 2016 0.78
18 Mind the gap: difference between Framingham heart age and real age increases with age in HIV-positive individuals-a clinical cohort study. BMJ Open 2013 0.76
19 Anaphylactic shock due to cefuroxime in a patient taking penicillin prophylaxis. Paediatr Anaesth 2002 0.75
20 Changes in Cognitive Function Over 96 weeks in Naïve Patients Randomised to Darunavir-ritonavir plus either Raltegravir or Tenofovir-Emtricitabine: a substudy of the NEAT001/ANRS143 trial. J Acquir Immune Defic Syndr 2016 0.75
21 Hepatitis B, hepatitis C and mortality among HIV-positive individuals. AIDS 2017 0.75
22 Switching from a ritonavir-boosted protease inhibitor to a dolutegravir-based regimen for maintenance of HIV viral suppression in patients with high cardiovascular risk. AIDS 2017 0.75